betaine has been researched along with Dyslipidemias in 3 studies
glycine betaine : The amino acid betaine derived from glycine.
Dyslipidemias: Abnormalities in the serum levels of LIPIDS, including overproduction or deficiency. Abnormal serum lipid profiles may include high total CHOLESTEROL, high TRIGLYCERIDES, low HIGH DENSITY LIPOPROTEIN CHOLESTEROL, and elevated LOW DENSITY LIPOPROTEIN CHOLESTEROL.
Excerpt | Relevance | Reference |
---|---|---|
" In this study, we examined the influence of betaine on high-fructose-induced renal damage involving renal inflammation, insulin resistance and lipid accumulation in rats and explored its possible mechanisms." | 3.80 | Betaine supplementation protects against high-fructose-induced renal injury in rats. ( Fan, CY; Ge, CX; Kong, LD; Li, JM; Wang, MX; Wang, X, 2014) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Zhang, T | 1 |
Lu, R | 1 |
Chen, Y | 1 |
Yuan, Y | 1 |
Song, S | 1 |
Yan, K | 1 |
Zha, Y | 1 |
Zhuang, W | 1 |
Cheng, Y | 1 |
Liang, J | 1 |
Fan, CY | 1 |
Wang, MX | 1 |
Ge, CX | 1 |
Wang, X | 1 |
Li, JM | 1 |
Kong, LD | 1 |
Davidson, MH | 1 |
3 other studies available for betaine and Dyslipidemias
Article | Year |
---|---|
Hyperhomocysteinemia and dyslipidemia in point mutation G307S of cystathionine β-synthase-deficient rabbit generated using CRISPR/Cas9.
Topics: Animals; Betaine; Body Weight; CRISPR-Cas Systems; Cystathionine beta-Synthase; Disease Models, Anim | 2020 |
Betaine supplementation protects against high-fructose-induced renal injury in rats.
Topics: Animals; Betaine; Cytokines; Dietary Supplements; Dyslipidemias; Fructose; Hyperuricemia; Inflammati | 2014 |
A clinical puzzle: fibrates and homocysteine elevation: editorial to: "fibrates may cause an abnormal urinary betaine loss which is associated with elevations in plasma homocysteine" by M. Lever et al.
Topics: Animals; Betaine; Bezafibrate; Clofibric Acid; Dyslipidemias; Folic Acid; Homocysteine; Humans; Hypo | 2009 |